The present invention relates to a multilayer tablet formulation comprising tenofovir or a pharmaceutically acceptable salt thereof and entecavir or a pharmaceutically acceptable salt thereof. The present invention further relates to a process for preparing such a formulation and to the use thereof in the treatment of chronic hepatitis B.